- Home
- ACIU vs SEVN Comparison
ACIU vs SEVN Comparison
Compare ACIU & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | SEVN |
|---|---|---|
| Founded | 2003 | 1986 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 191.2M |
| IPO Year | 2015 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ACIU | SEVN |
|---|---|---|
| Price | $3.32 | $8.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $10.00 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 329.8K | 87.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | ★ $29,383,000.00 |
| Revenue This Year | $635.38 | $27.75 |
| Revenue Next Year | $232.58 | $4.06 |
| P/E Ratio | ★ N/A | $8.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.43 | $8.23 |
| 52 Week High | $4.00 | $13.02 |
Technical Indicators
Market Signals| Indicator | ACIU | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 60.92 | 41.59 |
| Support Level | $3.18 | $8.33 |
| Resistance Level | $3.92 | $8.95 |
| Average True Range (ATR) | 0.21 | 0.16 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 92.42 | 27.27 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.